Avantor's net income is $-580M, below the Healthcare sector average of $16B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
The latest net income for AVTR is $-580M as of June 2026. That compares with $690M in the prior-year period — down 184.1% year over year. That is below the Healthcare sector average of $16B. Investors often review this figure alongside Avantor's historical trend and sector peers before judging valuation or financial health.
Over the past year, AVTR's net income moved from $690M to $-580M — a 184.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Avantor's operating scale or balance-sheet position.
Against Healthcare companies, AVTR currently prints $-580M for net income, while the sector average sits near $16B. That is roughly 103.5% below the sector mean. Large gaps often invite a closer look at Avantor's growth, margins, and balance sheet.
A net income figure of $-580M for AVTR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.
After noting AVTR's net income ($-580M), review year-over-year change from $690M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.